Zobrazeno 1 - 10
of 398
pro vyhledávání: '"C Kirwan"'
Autor:
George Boundouki, Paula Duxbury, Laura Ballance, Julie Wray, Vivienne Appanah, Ibrahim Ibrahim, James R Harvey, Julia R Henderson, Cliona C Kirwan, Richard J Jackson, Rebecca Louise Wilson, Rajiv V Dave
Publikováno v:
BMJ Open, Vol 14, Iss 8 (2024)
Objective This study aims to prioritise the themes identified from the three gap analyses performed by a combination of scientists, clinicians, patients and members of the public to determine areas in breast cancer care where research is lacking. We
Externí odkaz:
https://doaj.org/article/80ce2b437824447d9ceedc54961f3edd
Autor:
Adrian Murray Brunt, Joanne S Haviland, Duncan A Wheatley, Mark A Sydenham, David J Bloomfield, Charlie Chan, Suzy Cleator, Charlotte E Coles, Ellen Donovan, Helen Fleming, David Glynn, Andrew Goodman, Susan Griffin, Penelope Hopwood, Anna M Kirby, Cliona C Kirwan, Zohal Nabi, Jaymini Patel, Elinor Sawyer, Navita Somaiah, Isabel Syndikus, Karen Venables, John R Yarnold, Judith M Bliss
Publikováno v:
Health Technology Assessment, Vol 27, Iss 25 (2023)
Background FAST-Forward aimed to identify a 5-fraction schedule of adjuvant radiotherapy delivered in 1 week that was non-inferior in terms of local cancer control and as safe as the standard 15-fraction regimen after primary surgery for early breast
Externí odkaz:
https://doaj.org/article/1d13e92e28404c31aa757bc6060cebd9
Autor:
L. Ballance, R. L. Wilson, C. C. Kirwan, G. Boundouki, V. P. Taxiarchi, B. G. Baker, V. Rusius, M. Rowland, J. R. Henderson, N. Marikakis, J. McAleer, J. R. Harvey, On Behalf of the Northwest Breast Research Collaborative
Publikováno v:
The Breast Journal, Vol 2023 (2023)
Background. Patients often ask about the time taken to return to activities of daily living (ADLs) after breast surgery, but there is a lack of data to give accurate guidance. We aimed to assess the feasibility of a study to determine the time taken
Externí odkaz:
https://doaj.org/article/564d6141ada046d3894b19a5dcf72689
Autor:
Rajiv V. Dave, Hannah Bromley, Vicky P. Taxiarchi, Elizabeth Camacho, Sumohan Chatterjee, Nicola Barnes, Gillian Hutchison, Paul Bishop, Cliona C. Kirwan, Ashu Gandhi
Publikováno v:
Breast, Vol 68, Iss , Pp 234-235 (2023)
Externí odkaz:
https://doaj.org/article/4b60a08f644d4ec2bd816878cbbf790d
Autor:
Indrani S. Bhattacharya, Joanne S. Haviland, Lesley Turner, Hilary Stobart, Ada Balasopoulou, Liba Stones, Anna M. Kirby, Cliona C. Kirwan, Charlotte E. Coles, Judith M. Bliss, on behalf of the PRIMETIME Trialists
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-10 (2021)
Abstract Background For patients with early breast cancer considered at very-low risk of local relapse, risks of radiotherapy may outweigh the benefits. Decisions regarding treatment omission can lead to patient uncertainty (decisional conflict), whi
Externí odkaz:
https://doaj.org/article/7a1b5a5ff7bc4201b41f218ffc1c17bc
Autor:
Narendra Nath Basu, James Hodson, Shaunak Chatterjee, Ashu Gandhi, Julie Wisely, James Harvey, Lyndsey Highton, John Murphy, Nicola Barnes, Richard Johnson, Lester Barr, Cliona C. Kirwan, Sacha Howell, Andrew D. Baildam, Anthony Howell, D. Gareth Evans
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Contralateral risk-reducing mastectomy (CRRM) rates have tripled over the last 2 decades. Reasons for this are multi-factorial, with those harbouring a pathogenic variant in the BRCA1/2 gene having the greatest survival benefit. On May 14th,
Externí odkaz:
https://doaj.org/article/5688cd59f9bd429381b2e9941fc6d5dd
Autor:
John Castle, Emma Blower, Nigel J. Bundred, James R. Harvey, Jecko Thachil, Andrea Marshall, Karina Cox, Silvia Cicconi, Chris Holcombe, Carlos Palmieri, Cliona C. Kirwan
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-11 (2020)
Abstract Background Breast cancer patients are at a four-fold increased risk of developing a venous thromboembolism (VTE), a major cause of death in this group. Conversely, coagulation factors promote tumour growth and metastasis. This has been evide
Externí odkaz:
https://doaj.org/article/6034727a1a5a448ea4b2a84673e1349f
Autor:
Hudhaifah Shaker, Nigel J. Bundred, Göran Landberg, Susan A. Pritchard, Harith Albadry, Sarah L. Nicholson, Lauren J. Harries, Jing Y. E. Heah, John Castle, Cliona C. Kirwan
Publikováno v:
Cancer Medicine, Vol 9, Iss 5, Pp 1768-1778 (2020)
Abstract Background Tumor stroma, of which fibroblasts are the most abundant cell, resembles a non‐healing wound, where a procoagulant environment creates a permissive milieu for cancer growth. We aimed to determine if tumor expression of coagulati
Externí odkaz:
https://doaj.org/article/f8cbc09ec78246c7b08d0b699a5cd27f
Publikováno v:
Thrombosis Update, Vol 5, Iss , Pp 100066- (2021)
Circulating Tumour Cells (CTCs), the mechanism by which cancer spreads from the primary tumour to distant metastatic sites and cancer-associated thrombosis (CAT), a systemic hypercoagulable state found in many cancer patients, appear to have a symbio
Externí odkaz:
https://doaj.org/article/8b6c74a2f7824daa9a88bf9584aa7c5c
Autor:
A.M. Kirby, J.S. Haviland, M. Mackenzie, H. Fleming, C. Anandadas, S. Wickers, E. Miles, N. Iles, J.M. Bliss, C.E. Coles, C. Taylor, C. Kirwan, D. Lines, E. Provenzano, I. Gleeson, I. Bhattacharya, J. Wolstenholme, M. Aznar, M. Merchant, P. Howe, R. Butt, S. Gulliford, S. Settatree, S. McMahon, T. Richards, Y. Tsang, F. Cafferty, C. Toms, E. Redman, K. Biscombe
Publikováno v:
Clinical Oncology. 35:347-350
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc982bb779bac74774bd972f1938c219
https://doi.org/10.1016/j.clon.2023.02.015
https://doi.org/10.1016/j.clon.2023.02.015